Kurt Von Emster is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 21,175 shares of JSPR, which is worth approximately $466,485. The most recent transaction as insider was on Apr 13, 2023, when has been sold 9,075 shares (Voting Common Stock) at a price of $1.49 per share, resulting in proceeds of $13,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.2K
0% 3M change
0% 12M change
Total Value Held $466,485

KURT VON EMSTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2023
SELL
Open market or private sale
$13,521 $1.49 p/Share
9,075 Reduced 30.0%
21,175 Voting Common Stock
Oct 12 2022
BUY
Grant, award, or other acquisition
-
30,250 Added 50.0%
30,250 Voting Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
PCVX
Vaxcyte, Inc. Healthcare
CBAY
CymaBay Therapeutics, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
KVE

Kurt Von Emster

Director
Foster City, CA

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR